I am advised that a National Therapeutics Advisory Group has been established by the HSE to evaluate, advise, and provide recommendations on all therapeutics with potential for use in the treatment of COVID-19 in Ireland. This Group has developed clinical guidance and recommendations on the use of existing and emerging approved COVID-19 therapeutic medications, including Novel COVID-19 Antivirals and Novel COVID-19 Monoclonal Antibody Therapies. A Clinical Prioritisation Framework, that includes blood cancer patients, is being finalised and it is expected that it will shortly be made available publicly.